SCHEMBL13459594

SCHEMBL13459594

Cn1ccc2ccc(NC(=O)Nc3ccc(-c4cccc5cnccc45)cc3)cc21

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HTR2B P41595 2/20 0.53
▸ CYP3A4 P08684 2/20 0.53
▸ KDM4E B2RXH2 1/20 0.53
▸ MEN1 O00255 1/20 0.53
▸ TP53 P04637 1/20 0.53
▸ CYP1A2 P05177 1/20 0.53
▸ CYP2D6 P10635 1/20 0.53
▸ MAPT P10636 1/20 0.53
▸ CYP2C19 P33261 1/20 0.53
▸ RECQL P46063 1/20 0.53
▸ KMT2A Q03164 1/20 0.53
▸ TDP1 Q9NUW8 1/20 0.53
▸ HTR2C P28335 2/20 0.52
▸ KDR P35968 2/20 0.48
▸ TRPV1 Q8NER1 6/20 0.47
▸ IMPDH2 P12268 6/20 0.46
▸ NTSR1 P30989 1/20 0.45
▸ AURKA O14965 1/20 0.42
▸ ROCK2 O75116 1/20 0.42
▸ ERBB2 P04626 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13459817 0.80 TRPV1 (0.53) CYP3A4KDM4EKDRTRPV1IMPDH2
SCHEMBL8945056 0.78 MAPT (0.67) HTR2BCYP3A4KDM4EMEN1TP53
SCHEMBL13459838 0.78 MEN1 (0.55) CYP3A4KDM4EMEN1TP53CYP1A2
SCHEMBL9400617 0.78 MEN1 (0.82) HTR2BCYP3A4KDM4EMEN1TP53
Hydrochloric Acid SCHEMBL9400545 0.77 HTR2C (0.82) HTR2BCYP3A4KDM4EMEN1TP53
SCHEMBL13459571 0.77 IMPDH2 (0.51) CYP3A4MAPTKDRTRPV1IMPDH2
SCHEMBL13632604 0.76 KDR (0.59) MEN1TP53KMT2AKDRTRPV1
SCHEMBL13459539 0.76 EGFR (0.60) KDM4EMEN1MAPTKMT2AKDR
SCHEMBL13459834 0.74 CYP3A4 (0.58) CYP3A4KDM4EMEN1MAPTKMT2A
SCHEMBL13459592 0.74 RIPK1 (0.69) KDRTRPV1CSF1RFLT1FLT4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010032986-A2 NOVEL 5-(4-AMINOPHENYL)-ISOQUINOLINE DERIVATIVE, PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, PRODUCTION METHOD FOR SAME, AND COMPOSITION CONTAINING SAME AS ACTIVE INGREDIENT FOR PROPHYLAXIS AND TREATMENT OF MEDICAL CONDITION INDUCED BY RAF KINASE HYPERACTIVITY 주식회사 이큐스팜 (KR) 2010-03-25 — — WO disclosed
Send feedback